Isaac Ro
About Isaac Ro
Isaac Ro is a board member involved in advancing small molecule drug discovery, having played a key role in strategic appointments and collaborations.
Isaac Ro Board Member Role
Isaac Ro serves as a board member and has been involved in several significant appointments and collaborations for the company. His strategic vision is reflected in the appointment of key figures like Adrian Schreyer, Ph.D., as Chief Technology Officer and pharmaceutical R&D veteran Ryan Kruger as Chief Scientific Officer. These appointments aim to further the company's mission in advancing small molecule drug discovery.
Multi-Target Collaboration for Small Molecule Therapeutics
Isaac Ro announced a multi-target collaboration aimed at discovering small molecule therapeutics for multiple indications. This initiative is a crucial step for the company as it seeks to expand its pipeline and address various medical needs through innovative therapeutic solutions. The collaboration underscores the company's commitment to leveraging cutting-edge technology to develop effective drug candidates.
Strengthening the Board of Directors
In a strategic move to enhance governance and guide the company's future initiatives, Isaac Ro played a key role in strengthening the Board of Directors. This effort included the appointment of Robert Forrester alongside Isaac Ro himself. These appointments are intended to bring diverse expertise and leadership skills to the board, fostering better decision-making and strategic planning.
Series A Funding Led by Catalio
Isaac Ro was instrumental in closing a $30 million Series A funding round led by Catalio. This funding is aimed at advancing the company's small molecule drug discovery efforts using a novel, directed evolution platform. The infusion of capital will support ongoing research and development activities, enabling the company to accelerate its drug discovery process and bring new therapeutics to market.
Company Location and Contact Information
The company is located at 20 Maguire Rd Suite 302, Lexington, MA 02421. For inquiries or further information, the contact number is (978) 444-2649. This location serves as the central hub for the company's operations, where key strategic decisions and research activities are conducted.